期刊文献+

真实世界临床研究的分类和设计要点浅谈

Critical points of real world clinical study classification and design
下载PDF
导出
摘要 真实世界研究是临床试验和药品上市后再评价药物疗效的一种现代医学研究新方法。作为临床研究的一种新形式,真实世界研究同样须遵循临床研究的一般原则,良好的设计、高质量的数据和可靠的统计方法能促使高质量真实世界证据的产生。随着信息化技术的发展和大数据时代的来临及医学研究数据的可及性和采集便捷性大幅提升,真实世界研究成为医学研究的热点之一。基于真实世界研究产生的真实世界证据提供了洞察药物和医疗器械在日常医疗实践中实际的使用方式、使用问题以及毒性和疗效结果的真实信息,这种研究方法及其产生的真实世界证据逐渐得到了临床医学领域专家的认可。 Real world study is a new modern medical approach for clinical trials and post-marketing re-evaluation of drug efficacy and must also follow the general principles of clinical research as a new form of clinical research.Good design,high-quality data and reliable statistical methods can lead to high-quality real world evidence.With the development of information technology and the advent of the era of big data as well as the significant improvement of the accessibility and collection of medical research data,real world study has become one of the hot spots in medical research.Real world evidence based on real world study can provide insight into the actual use of drugs and medical devices in daily medical practice as well as real information about the problems of their use,and the toxicity and efficacy outcomes,and this approach and the real world evidence generated by this research are gradually gaining recognition among experts in clinical medicine.
作者 王瑞平 WANG Ruiping(Clinical Research&Innovation Center,Shanghai Skin Disease Hospital,Shanghai 200443,China)
出处 《上海医药》 CAS 2022年第23期63-67,共5页 Shanghai Medical & Pharmaceutical Journal
基金 国家自然科学基金面上项目(82174383) 上海市皮肤病医院引进人才科研基金(2021KYQD01) 上海人才发展基金(2021073) 上海申康医院发展中心第二轮“三年行动计划”医企融合创新支撑技能培训专项(SHDC2022CRS053)。
关键词 真实世界 临床研究 设计要点 研究分类 real world clinical research critical design points study classification
  • 相关文献

参考文献2

二级参考文献20

  • 1陆光伟.中药归经及其成分在体内的分布[J].中成药,1984(5):38-39. 被引量:40
  • 2严灿,徐志伟.肝主疏泄调畅情志功能的中枢神经生物学机制探讨[J].中国中西医结合杂志,2005,25(5):459-462. 被引量:128
  • 3Camenzind E, Steg PG, Wijins W, et al. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation, 2007, 115 ( 11 ) : 1440-1455.
  • 4Nordmann AJ, Briel M, Bucher HC, et al. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J, 2006, 27 (23) :2784-2814.
  • 5Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol,2006,48(12) :2584-2591.
  • 6Lagerqvist B, James SK, Wallentin L, et al. SCAAR Study Group. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med, 2007, 356 (10) : 1009- 1019.
  • 7Stone GW, Jeffrey W, Moses, et al. Satety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med, 2007, 356(10) :998-1008.
  • 8Spaulding C, Daemen J, Boersma E, et al. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stnes. N Engl J Med, 2007,356(10) :989-997.
  • 9Kastrati A, Mehilli J, Schomig A, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med, 2007, 356(10) : 1030-1039.
  • 10Mauri L, Hsieh WH, Cutlip DE, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med, 2007, 356(10) : 1020-1029.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部